India’s pharmaceutical exports registered slowest growth in at least 15 years at 1.2 per cent to $14.84 billion last fiscal amid growing tension with the US over intellectual property rights related issues.
As the IPR issues raised by the US — India’s biggest market — are unlikely to be resolved anytime soon, industry observers say that pharma exports will miss the target of $25 billion set for 2014-15 in a government strategy paper.
According to the Commerce Ministry data, in 2012-13, the country’s pharma exports aggregated $14.66 billion.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.